Revenue Summary of AstraZeneca PLC

AstraZeneca PLC's latest annual revenue in 2023 was 45.81 Billion USD , up 3.29% from previous year.
AstraZeneca PLC's latest quarterly revenue in 2024 Q2 was 12.93 Billion USD , up 2.04% from previous quarter.
AstraZeneca PLC reported a annual revenue of 44.35 Billion USD in annual revenue 2022, up 18.53% from previous year.
AstraZeneca PLC reported a annual revenue of 37.41 Billion USD in annual revenue 2021, up 40.58% from previous year.
AstraZeneca PLC reported a quarterly revenue of 12.67 Billion USD for 2024 Q1, up 5.45% from previous quarter.
AstraZeneca PLC reported a quarterly revenue of 11.49 Billion USD for 2023 Q3, up 0.67% from previous quarter.

Annual Revenue Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Revenue of AstraZeneca PLC (2023 - 1990)

Year	Revenue	Revenue Growth
2023	45.81 Billion USD	3.29%
2022	44.35 Billion USD	18.53%
2021	37.41 Billion USD	40.58%
2020	26.61 Billion USD	9.16%
2019	24.38 Billion USD	10.38%
2018	22.09 Billion USD	-1.67%
2017	22.46 Billion USD	-2.33%
2016	23 Billion USD	-6.9%
2015	24.7 Billion USD	-5.32%
2014	26.09 Billion USD	1.49%
2013	25.71 Billion USD	-8.09%
2012	27.97 Billion USD	-16.72%
2011	33.59 Billion USD	0.97%
2010	33.26 Billion USD	1.42%
2009	32.8 Billion USD	3.81%
2008	31.6 Billion USD	6.91%
2007	29.55 Billion USD	11.65%
2006	26.47 Billion USD	10.54%
2005	23.95 Billion USD	11.78%
2004	21.42 Billion USD	13.67%
2003	18.84 Billion USD	5.6%
2002	17.84 Billion USD	-24.27%
2001	23.57 Billion USD	30.11%
2000	18.11 Billion USD	-1.74%
1999	18.43 Billion USD	101.57%
1998	9.14 Billion USD	6.52%
1997	8.58 Billion USD	-6.51%
1996	9.18 Billion USD	21.35%
1995	7.56 Billion USD	8.06%
1994	7 Billion USD	6.64%
1993	6.56 Billion USD	8.83%
1992	6.03 Billion USD	-17.91%
1991	7.35 Billion USD	0.04%
1990	7.34 Billion USD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	12.93 Billion USD	2.04%
2024 Q1	12.67 Billion USD	5.45%
2023 Q3	11.49 Billion USD	0.67%
2023 Q4	12.02 Billion USD	4.63%
2023 FY	45.81 Billion USD	3.29%
2023 Q1	10.87 Billion USD	-2.93%
2023 Q2	11.41 Billion USD	4.94%
2022 Q4	11.2 Billion USD	2.05%
2022 Q2	10.77 Billion USD	-5.43%
2022 FY	44.35 Billion USD	18.53%
2022 Q3	10.98 Billion USD	1.96%
2022 Q1	11.39 Billion USD	-5.17%
2021 Q4	12.01 Billion USD	21.74%
2021 FY	37.41 Billion USD	40.58%
2021 Q1	7.32 Billion USD	-1.21%
2021 Q2	8.22 Billion USD	12.3%
2021 Q3	9.86 Billion USD	20.02%
2020 Q2	6.27 Billion USD	-1.24%
2020 FY	26.61 Billion USD	9.16%
2020 Q1	6.35 Billion USD	-4.65%
2020 Q3	6.57 Billion USD	4.83%
2020 Q4	7.41 Billion USD	12.65%
2019 Q1	5.49 Billion USD	-14.43%
2019 FY	24.38 Billion USD	10.38%
2019 Q4	6.66 Billion USD	4.03%
2019 Q3	6.4 Billion USD	10.01%
2019 Q2	5.82 Billion USD	6.05%
2018 FY	22.09 Billion USD	-1.67%
2018 Q1	5.17 Billion USD	-10.37%
2018 Q2	5.15 Billion USD	-0.44%
2018 Q3	5.34 Billion USD	3.59%
2018 Q4	6.41 Billion USD	20.17%
2017 Q3	6.23 Billion USD	23.38%
2017 FY	22.46 Billion USD	-2.33%
2017 Q4	5.77 Billion USD	-7.3%
2017 Q2	5.05 Billion USD	-6.55%
2017 Q1	5.4 Billion USD	-3.22%
2016 Q4	5.58 Billion USD	-2.0%
2016 FY	23 Billion USD	-6.9%
2016 Q2	5.6 Billion USD	-8.37%
2016 Q1	6.11 Billion USD	-4.44%
2016 Q3	5.69 Billion USD	1.71%
2015 Q3	5.94 Billion USD	-5.74%
2015 Q2	6.3 Billion USD	4.13%
2015 FY	24.7 Billion USD	-5.32%
2015 Q4	6.39 Billion USD	7.64%
2015 Q1	6.05 Billion USD	-9.37%
2014 Q2	6.45 Billion USD	0.59%
2014 Q3	6.54 Billion USD	1.36%
2014 FY	26.09 Billion USD	1.49%
2014 Q1	6.41 Billion USD	-6.25%
2014 Q4	6.68 Billion USD	2.16%
2013 Q3	6.25 Billion USD	0.29%
2013 Q2	6.23 Billion USD	-2.4%
2013 FY	25.71 Billion USD	-8.09%
2013 Q1	6.38 Billion USD	-12.32%
2013 Q4	6.84 Billion USD	9.5%
2012 Q4	7.28 Billion USD	8.98%
2012 Q3	6.68 Billion USD	0.33%
2012 Q1	7.34 Billion USD	-15.1%
2012 FY	27.97 Billion USD	-16.72%
2012 Q2	6.66 Billion USD	-9.38%
2011 Q3	8.21 Billion USD	-2.57%
2011 FY	33.59 Billion USD	0.97%
2011 Q4	8.65 Billion USD	5.39%
2011 Q2	8.43 Billion USD	1.66%
2011 Q1	8.29 Billion USD	-3.77%
2010 Q4	8.61 Billion USD	9.1%
2010 FY	33.26 Billion USD	1.42%
2010 Q1	8.57 Billion USD	-4.13%
2010 Q3	7.89 Billion USD	-3.42%
2010 Q2	8.17 Billion USD	-4.64%
2009 FY	32.8 Billion USD	3.81%
2009 Q3	8.2 Billion USD	3.04%
2009 Q4	8.94 Billion USD	9.09%
2009 Q1	7.7 Billion USD	-6.01%
2009 Q2	7.95 Billion USD	3.34%
2008 Q1	7.67 Billion USD	-6.03%
2008 Q3	7.77 Billion USD	-2.28%
2008 Q4	8.19 Billion USD	5.38%
2008 Q2	7.95 Billion USD	3.63%
2008 FY	31.6 Billion USD	6.91%
2007 Q3	7.15 Billion USD	-1.69%
2007 Q4	8.17 Billion USD	14.27%
2007 Q2	7.27 Billion USD	4.41%
2007 FY	29.55 Billion USD	11.65%
2007 Q1	6.96 Billion USD	-2.63%
2006 Q3	6.51 Billion USD	-1.65%
2006 Q2	6.62 Billion USD	7.2%
2006 Q1	6.18 Billion USD	-1.69%
2006 FY	26.47 Billion USD	10.54%
2006 Q4	7.15 Billion USD	9.79%
2005 Q2	6.13 Billion USD	6.77%
2005 Q4	6.28 Billion USD	8.59%
2005 Q3	5.78 Billion USD	-5.59%
2005 Q1	5.74 Billion USD	-0.97%
2005 FY	23.95 Billion USD	11.78%
2004 Q2	5.28 Billion USD	4.22%
2004 Q4	5.79 Billion USD	10.14%
2004 Q3	5.26 Billion USD	-0.43%
2004 FY	21.42 Billion USD	13.67%
2004 Q1	5.07 Billion USD	4.08%
2003 Q1	4.74 Billion USD	0.55%
2003 FY	18.84 Billion USD	5.6%
2003 Q4	4.87 Billion USD	2.04%
2003 Q3	4.77 Billion USD	7.27%
2003 Q2	4.45 Billion USD	-6.09%
2002 FY	17.84 Billion USD	-24.27%
2002 Q4	4.71 Billion USD	10.44%
2002 Q2	4.31 Billion USD	-2.62%
2002 Q1	4.42 Billion USD	-61.52%
2002 Q3	4.27 Billion USD	-0.95%
2001 Q2	4.09 Billion USD	3.04%
2001 Q4	11.5 Billion USD	191.29%
2001 Q3	3.95 Billion USD	-3.64%
2001 FY	23.57 Billion USD	30.11%
2001 Q1	3.97 Billion USD	-38.58%
2000 Q1	3.88 Billion USD	-23.99%
2000 Q3	3.77 Billion USD	-5.09%
2000 Q4	6.47 Billion USD	71.6%
2000 FY	18.11 Billion USD	-1.74%
2000 Q2	3.97 Billion USD	2.32%
1999 Q1	4.52 Billion USD	139.56%
1999 FY	18.43 Billion USD	101.57%
1999 Q2	4.52 Billion USD	0.0%
1999 Q3	4.27 Billion USD	-5.36%
1999 Q4	5.11 Billion USD	19.51%
1998 FY	9.14 Billion USD	6.52%
1998 Q3	2.33 Billion USD	-3.61%
1998 Q1	2.41 Billion USD	5.66%
1998 Q4	1.88 Billion USD	-19.0%
1998 Q2	2.41 Billion USD	0.0%
1997 Q4	2.28 Billion USD	8.99%
1997 Q1	2.28 Billion USD	-49.88%
1997 Q3	2.09 Billion USD	-8.08%
1997 FY	8.58 Billion USD	-6.51%
1997 Q2	2.28 Billion USD	0.0%
1996 FY	9.18 Billion USD	21.35%
1996 Q2	2.27 Billion USD	0.0%
1996 Q3	2.31 Billion USD	1.54%
1996 Q4	4.55 Billion USD	96.97%
1996 Q1	2.27 Billion USD	29.2%
1995 Q3	1.93 Billion USD	-4.07%
1995 Q1	2.01 Billion USD	10.43%
1995 FY	7.56 Billion USD	8.06%
1995 Q4	1.76 Billion USD	-8.86%
1995 Q2	2.01 Billion USD	-0.0%
1994 Q1	1.83 Billion USD	19.77%
1994 Q2	1.83 Billion USD	0.0%
1994 Q4	1.82 Billion USD	4.21%
1994 FY	7 Billion USD	6.64%
1994 Q3	1.75 Billion USD	-4.57%
1993 Q3	1.53 Billion USD	-12.1%
1993 Q4	1.53 Billion USD	-0.22%
1993 Q1	1.74 Billion USD	0.0%
1993 Q2	1.74 Billion USD	0.0%
1993 FY	6.56 Billion USD	8.83%
1992 FY	6.03 Billion USD	-17.91%
1991 FY	7.35 Billion USD	0.04%
1990 FY	7.34 Billion USD	0.0%

Peer Revenue Comparison of AstraZeneca PLC

Name	Revenue	Revenue Difference
Amgen Inc.	28.19 Billion USD	-62.508%
Biogen Inc.	9.83 Billion USD	-365.767%
Gilead Sciences, Inc.	27.11 Billion USD	-68.945%
MIRA Pharmaceuticals, Inc.	- USD	-Infinity%
Scilex Holding Company	46.74 Million USD	-97906.119%
Scilex Holding Company	46.74 Million USD	-97906.119%

Global Stocks Search

AstraZeneca PLC (AZN)

Revenue Summary of AstraZeneca PLC

Annual Revenue Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Revenue of AstraZeneca PLC (2023 - 1990)

Peer Revenue Comparison of AstraZeneca PLC